Deciphering the ways cannabis acts in the body to alter appetite could lead to new treatments for illness-induced anorexia common in cancer, HIV/AIDS, heart disease, and some metabolic disorders.
To date, the only cure for SCD is a bone marrow transplant, which is costly and out of reach for most patients.
Digipath is pleased to announce that Dr. Yunfeng Pan, PhD, has joined Digipath Labs as its Analytical Laboratory Director with oversight of analytical testing procedures.
Researchers at ebbu are using human clinical studies to track and record how different strains affect different patients to help users find the cannabis product they want and need.
The Palm Desert facility will offer comprehensive compliance testing services in addition to research and development into new cannabis products.
The market for cannabis and hemp products has seen a low-key but potentially huge step forward in recent weeks.
An Australian study of medicinal cannabis used to treat childhood epilepsy has found most samples contained some THC and little CBD, contrary to parents' expectations.
A four-year study suggests medicinal cannabis is not as effective at relieving chronic non-cancer pain as commonly assumed.
A majority of Australian GPs support medicinal cannabis being available on prescription, with their preferred "access model" involving trained GPs prescribing independently of specialists.